Dambkowski Carl

Dambkowski Carl is listed in filings as Chief Medical Officer at Apogee Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Apogee Therapeutics, Inc. (APGE) and Oruka Therapeutics, Inc. (ORKA). The current snapshot covers public activity from Aug 9, 2024 to Jun 5, 2026. Reported amounts are shown as $432.9K to $3.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.